CS
LEGN icon

Credit Suisse’s Legend Biotech LEGN Stock Holding History

Credit Suisse’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$6.59M Buy
117,505
+6,201
+6% +$374K 0.01% 1150
2023
Q4 		$6.7M Buy
111,304
+29,964
+37% +$1.9M 0.01% 1161
2023
Q3 		$5.46M Sell
81,340
-1,582
-2% -$110K 0.01% 1218
2023
Q2 		$5.72M Buy
82,922
+9,203
+12% +$601K 0.01% 1251
2023
Q1 		$3.55M Buy
73,719
+9,228
+14% +$451K ﹤0.01% 1531
2022
Q4 		$3.22M Sell
64,491
-5,100
-7% -$247K ﹤0.01% 1601
2022
Q3 		$2.84M Sell
69,591
-46,488
-40% -$2.18M ﹤0.01% 1617
2022
Q2 		$6.38M Sell
116,079
-19,899
-15% -$840K 0.01% 1144
2022
Q1 		$4.94M Buy
135,978
+26,154
+24% +$1.03M ﹤0.01% 1454
2021
Q4 		$5.12M Buy
109,824
+92,981
+552% +$4.72M ﹤0.01% 2005
2021
Q3 		$852K Buy
16,843
+2,466
+17% +$103K ﹤0.01% 3464
2021
Q2 		$590K Sell
14,377
-2,116
-13% -$71.9K ﹤0.01% 3740
2021
Q1 		$478K Buy
16,493
+3,318
+25% +$90.5K ﹤0.01% 3799
2020
Q4 		$371K Buy
+13,175
New +$379K ﹤0.01% 3909

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Credit Suisse's LEGN Position: Q1 2024 in Review

Credit Suisse increased its Legend Biotech (LEGN) stake by 5.6% in Q1 2024, buying an estimated $374K and bringing the position to 117,505 shares worth $6.59M. The position accounts for 0.01% of the portfolio, ranked #1150.

Credit Suisse first reported a position in LEGN in Q4 2020 and has held it in 14 quarters since. The position peaked at $6.7M in Q4 2023. 192 funds tracked by Wall St. Rank hold LEGN as of Q1 2024.

  • Credit Suisse held 117,505 shares of Legend Biotech worth $6.59M as of Q1 2024.
  • Credit Suisse bought 6,201 Legend Biotech shares in Q1 2024, an estimated $374K.
  • Legend Biotech made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #1150 holding.
  • Credit Suisse first reported a position in Legend Biotech in Q4 2020 and has held it in 14 quarters since.
  • Credit Suisse's Legend Biotech position peaked at $6.7M in Q4 2023.
  • 192 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.